文献速递瘢痕与激光

瘢痕疙瘩中胚胎干细胞样群体表达组织蛋白酶B、D、G

Expression of Cathepsins B, D, and G by the Embryonic Stem Cell-Like Population within Human Keloid Tissues and Keloid-Derived Primary Cell Lines.
PubMed 文献 · Plast Reconstr Surg · 2019-01-01

该研究在11例瘢痕疙瘩组织中用免疫组化检测组织蛋白酶B、D、G,并对5例组织和4株原代细胞系行蛋白、mRNA及酶活性分析。结果显示三种组织蛋白酶在瘢痕疙瘩相关淋巴组织中胚胎干细胞样群体表达,可能参与旁路激活肾素-血管紧张素系统,提示治疗靶点。

要点

  • 组织蛋白酶B、D、G在瘢痕疙瘩组织及原代细胞系中表达。
  • 组织蛋白酶B和D定位于微血管内皮,G定位于类胰蛋白酶阳性血管周细胞。
  • 组织蛋白酶B和D具有功能活性,可能旁路激活肾素-血管紧张素系统。

核心结论

  • 组织蛋白酶B、D、G由瘢痕疙瘩相关淋巴组织中的胚胎干细胞样群体表达,可能旁路激活肾素-血管紧张素系统,提示肾素-血管紧张素系统调节剂和组织蛋白酶抑制剂为潜在治疗靶点。

研究设计与样本

  • 对11例瘢痕疙瘩组织行DAB免疫组化染色,其中3例行免疫荧光共染CD34、类胰蛋白酶和OCT4。
  • 对5例瘢痕疙瘩组织和4株瘢痕疙瘩原代细胞系行Western blot、RT-qPCR和酶活性检测。

主要发现

  • DAB免疫组化显示15例瘢痕疙瘩组织均表达组织蛋白酶B、D、G。
  • 免疫荧光显示组织蛋白酶B和D定位于瘢痕疙瘩相关淋巴组织微血管内皮,组织蛋白酶G定位于类胰蛋白酶阳性血管周细胞。
  • Western blot证实组织蛋白酶B和D在瘢痕疙瘩组织和原代细胞系中的半定量水平。
  • RT-qPCR显示组织蛋白酶B和D在组织和细胞系中转录激活,组织蛋白酶G在组织中转录激活。
  • 酶活性检测证实组织蛋白酶B和D具有功能活性。

临床怎么用

  • 提示肾素-血管紧张素系统调节剂和组织蛋白酶抑制剂可能成为瘢痕疙瘩治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The authors have previously shown that an embryonic stem cell-like population within keloid-associated lymphoid tissues in keloid lesions expresses components of the renin-angiotensin system that may be dysregulated. The authors hypothesized that cathepsins B, D, and G are present within the embryonic stem cell-like population in keloid lesions and contribute to bypass loops of the renin-angiotensin system. METHODS: 3,3'-Diaminobenzidine immunohistochemical staining for cathepsins B, D, and G was performed on formalin-fixed paraffin-embedded sections in keloid tissue samples of 11 patients. Immunofluorescence immunohistochemical staining was performed on three of these keloid tissue samples, by co-staining with CD34, tryptase, and OCT4. Western blotting, reverse transcription quantitative polymerase chain reaction, and enzyme activity assays were performed on five keloid tissue samples and four keloid-derived primary cell lines to investigate protein and mRNA expression, and functional activity, respectively. RESULTS: 3,3'-Diaminobenzidine immunohistochemical staining demonstrated expression of cathepsins B, D, and G in all 15 keloid tissue samples. Immunofluorescence immunohistochemical staining showed localization of cathepsins B and D to the endothelium of microvessels within the keloid-associated lymphoid tissues and localization of cathepsin G to the tryptase-positive perivascular cells. Western blotting confirmed semiquantitative levels of cathepsins B and D in keloid tissue samples and keloid-derived primary cell lines. Reverse transcription quantitative polymerase chain reaction showed quantitative transcriptional activation of cathepsins B and D in keloid tissue samples and keloid-derived primary cell lines and cathepsin G in keloid tissue samples. Enzyme activity assays demonstrated functional activity of cathepsins B and D. CONCLUSION: Cathepsins B, D, and G are expressed by the embryonic stem cell-like population within the keloid-associated lymphoid tissues of keloid lesions and may act to bypass the renin-angiotensin system, suggesting a potential therapeutic target using renin-angiotensin system modulators and cathepsin inhibitors.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Paterson C, Lee VMY, Brasch HD, et al. Expression of Cathepsins B, D, and G by the Embryonic Stem Cell-Like Population within Human Keloid Tissues and Keloid-Derived Primary Cell Lines. Plast Reconstr Surg. 2019. PMID: 31764649. doi:10.1097/PRS.0000000000006275

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。